For decades, oncologists have had a powerful but imperfect ally in the fight against cancer: genomic testing. The ability to ...
Please provide your email address to receive an email when new articles are posted on . A functional precision medicine approach produced significant objective response, PFS in children with cancer.
When Dr. Maher Albitar left Houston for the first time, he wanted to bring the knowledge he’d picked up in the Texas Medical ...
SALT LAKE CITY, April 18, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (MYGN), (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Intermountain Precision Genomics, a service of ...
ACT Genomics today announced a significant upgrade to the ACTDrug® series, its next-generation sequencing (NGS) genomic ...
SAN DIEGO, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets the Saphyr® system, a genome imaging platform for ...
GAITHERSBURG, Md. & OAKLAND, Calif.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced its plans to acquire Fabric ...
Fort Lauderdale, FL, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Gattaca Genomics, a pioneering next generation company innovating solutions for reproductive health, is set to revolutionize family planning with ...
IRVINE, Calif. and SAN ANTONIO, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Targeted Genomics LLC, developer of GlutenID, the only U.S. Food and Drug Administration (FDA) cleared test for celiac genetics, today ...
VANCOUVER, British Columbia-- (BUSINESS WIRE)--Contextual Genomics, developers of genomics-based cancer tests, and the Personalized Medicine Initiative (PMI), an organization bringing molecular-based ...
Combining GeneDx’s industry-leading rare disease data asset and Fabric Genomics’ AI-powered platform furthers the Company’s leadership and creates an unrivaled platform to deliver global access to ...